The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19
Clinical trial NCT04273581 · UNKNOWN
Trial details
- NCT number
- NCT04273581
- Sponsor
- First Affiliated Hospital of Wenzhou Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-18
- Primary completion
- 2020-04-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.